Saturday, May 24
07:30 AM - 08:30 AM
Breakfast
Session VII Plenary: GLP-1, amylin & emerging energy expending therapies
08:30 AM - 08:55 AM
40
Therapeutic strategies targeting energy expenditureMichael P Czech
08:55 AM - 09:20 AM
41
Does it really take two to tango? GLP-1 vs. amylin therapies for obesity.James L Trevaskis
09:20 AM - 09:45 AM
42
Known knowns and known unknowns of amylin biologyThomas Lutz
09:45 AM - 10:10 AM
43
Amylin-based therapies for treatment of obesityDavid Hornigold
10:10 AM - 10:25 AM
44
targeting Neurofibrosis to potentiate Incretin TherapiesFeiyue Shi1, Cait A Beddows1, Emily A Canner1, Garron T Dodd1, Sagar Dalal2, Nicolle H Packer2, and Edward SX Moh2
10:25 AM - 10:40 AM
45
Pharmacological Activation of GPR139 by TAK-401 Modulates Energy Balance and Provides Insights into GPR139 Signaling Ester Dos Santos Alves1, Gabriela Batitucci1, Nicolly Porto Marin2, Igor Vinicius Sousa Cavalheiro2, Shannon O'Brien3, Natália Ferreira Mendes2, Davide Calebiro3, and Licio Augusto Velloso1
10:40 AM - 10:55 AM
46
Fluoroquinolone-like compounds promote weight loss and improve glycemic control in obese miceNiedson Correia de Lima Junior1, Gerson Profeta de Souza2, Linnéa Bergenholm3, Henver Simionato Brunetta4, Jessica Aparecida da Silva Pereira2, Fernanda Luísa Basei1, João Pedro Mazzi1, Letícia de Souza Figueiredo1, Gabriel Palermo Ruiz1, Deisi Braga Shimo1, Andrea Livia Silva Rocha5, Raul Gobato Costa1, Kauê de Oliveira Chinaglia1, José Luiz da Costa1, Jeremie Boucher3, Gavin O'Mahony3, and Marcelo Alves da Silva Mori1
10:55 AM - 11:55 AM
Coffee Break and Poster Viewing (Even Numbers)
Session VIII Plenary: Combination approaches, muscle function & future patient needs
11:55 AM - 12:20 PM
47
Antagonism vs. agonism for GIPR added to GLP-1 for weight lossMurielle Veniant-Ellison
12:20 PM - 12:45 PM
48
GLP-1 combinations for obesity therapyManu Chakravarthy
12:45 PM - 01:10 PM
49
Activin blockade approaches to improve muscle function during weight lossMark Sleeman
01:10 PM - 01:35 PM
50
Clinical Obesity (Lancet Commission); From Definition, Diagnosis, to Preliminary Prevalence RatesEric Ravussin
01:35 PM - 01:50 PM
51
Identification of novel regulators of mitochondrial function and energy metabolism in adipose tissue
Chunyan Wu1, Tongtong Wang1, Miroslav Balaz2, and Christian Wolfrum1
01:50 PM - 02:05 PM
52
Chronic urocortin 2 administration improves exercise capacity and metabolism in diet-induced obese miceJoe Brozinick, Andrew Ryan, Steve Bauer, Mark Wade, Natalie Janzen, and Pablo Vidal-Souza
02:05 PM - 03:00 PM
Lunch and Informal Discussions
03:00 PM - 07:30 PM
Informal Discussions
07:30 PM - 11:00 PM
Farewell Dinner
